Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer

Melatonin has numerous anti-cancer properties reported to influence cancer initiation, promotion, and metastasis. With the need for effective hormone therapies (HT) to treat menopausal symptoms without increasing breast cancer risk, co-administration of nocturnal melatonin with a natural, low-dose H...

Descripción completa

Detalles Bibliográficos
Autores principales: Dodda, Balasunder R., Bondi, Corry D., Hasan, Mahmud, Clafshenkel, William P., Gallagher, Katie M., Kotlarczyk, Mary P., Sethi, Shalini, Buszko, Ethan, Latimer, Jean J., Cline, J. Mark, Witt-Enderby, Paula A., Davis, Vicki L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636553/
https://www.ncbi.nlm.nih.gov/pubmed/31355130
http://dx.doi.org/10.3389/fonc.2019.00525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636553/
https://www.ncbi.nlm.nih.gov/pubmed/31355130
http://dx.doi.org/10.3389/fonc.2019.00525

Ejemplares similares